Compare COEP & GOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | GOCO |
|---|---|---|
| Founded | 2017 | 2001 |
| Country | United States | United States |
| Employees | 7 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 38.3M |
| IPO Year | N/A | 2020 |
| Metric | COEP | GOCO |
|---|---|---|
| Price | $12.00 | $1.65 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 33.4K | ★ 76.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $798,894,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.74 |
| 52 Week Low | $6.32 | $1.31 |
| 52 Week High | $21.41 | $14.14 |
| Indicator | COEP | GOCO |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 44.70 |
| Support Level | $11.76 | N/A |
| Resistance Level | $13.23 | $2.56 |
| Average True Range (ATR) | 0.90 | 0.18 |
| MACD | 0.05 | 0.03 |
| Stochastic Oscillator | 38.21 | 26.81 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
GoHealth Inc is a health insurance marketplace and Medicare-focused digital health company whose purpose is to compassionately ensure consumers' peace of mind when making healthcare decisions so consumers can focus on living life. It offers Medicare plans, including, but not limited to, Medicare Advantage, Medicare Supplement and prescription drug plans. Its proprietary technology platform leverages modern machine-learning algorithms, powered by over two decades of insurance purchasing behavior, to reimagine the process of matching a health plan to a consumer's specific needs.